Cinryze (C1 esterase inhibitor, human) — United Healthcare
Hereditary angioedema (HAE)
Initial criteria
- Diagnosis of hereditary angioedema (HAE)
- For prophylaxis against HAE attacks
- Not used in combination with other products indicated for prophylaxis against HAE attacks (e.g., Haegarda, Takhzyro, Orladeyo)
Approval duration
12 months